The Role of Lomefloxacin in the Treatment of Chronic Prostatitis
暂无分享,去创建一个
[1] S. Holm,et al. Can decreased phagocytosis and killing of autologous gram-positive bacteria explain the finding of gram-positive bacteria in "non-bacterial prostatitis"? , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.
[2] R. Alexander,et al. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. , 1997, Urology.
[3] J. Krieger,et al. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis , 1996, Journal of clinical microbiology.
[4] M. Huleihel,et al. Distinct expression levels of cytokines and soluble cytokine receptors in seminal plasma of fertile and infertile men. , 1996, Fertility and sterility.
[5] J. Heiman,et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. , 1996, The Journal of urology.
[6] A. Zisman,et al. Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia. , 1995, The Journal of urology.
[7] H. Ceri,et al. Antibiotic pharmacokinetics in the inflamed prostate. , 1995, The Journal of urology.
[8] J. Nickel,et al. Coagulase-negative staphylococcus in chronic prostatitis. , 1992, The Journal of urology.
[9] D. Hooper,et al. Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.
[10] I. S. Morse. Pharmacokinetics and safety of single oral doses of lomefloxacin. , 1990, Biopharmaceutics & drug disposition.
[11] J. Nickel,et al. Pathogenesis of chronic bacterial prostatitis in an animal model. , 1990, British journal of urology.
[12] J. Monk,et al. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. , 1987, Drugs.
[13] J. Domagala,et al. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. , 1986, Journal of medicinal chemistry.
[14] M. Depiante-Depaoli,et al. Experimental Autoimmune Damage to Rat Male Accessory Glands. II. T Cell Requirement in Adoptive Transfer of Specific Tissue Damage , 1984, American journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction.
[15] W. Weidner,et al. Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. , 1983, The Journal of infectious diseases.
[16] P. Kohnen,et al. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. , 1979, The Journal of urology.
[17] W. Fair,et al. The pH of prostatic fluid: a reappraisal and therapeutic implications. , 1978, Transactions of the American Association of Genito-Urinary Surgeons.
[18] T. Stamey,et al. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? , 1978, The Journal of urology.
[19] A. Pfau,et al. The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis. , 1978, The Journal of urology.
[20] T. Stamey,et al. Bacteriologic localization patterns in bacterial prostatitis and urethritis. , 1968, Investigative urology.
[21] J. Nickel,et al. Bacterial localization in antibiotic‐refractory chronic bacterial prostatitis , 1993, The Prostate.
[22] S. Clejan,et al. Prostate specific antigen and prostatitis II. PSA production and release kinetics in vitro , 1992, The Prostate.
[23] P. McDonald,et al. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils. , 1990, The Journal of antimicrobial chemotherapy.
[24] J. Dubois,et al. Antibacterial activity of lomefloxacin against urinary tract, gastrointestinal tract, and respiratory tract pathogens , 1989 .